Focal Segmental Glomerulosclerosis: Clinical Trials

1 trial for Focal Segmental Glomerulosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Recruiting 1

Follow Focal Segmental Glomerulosclerosis: new trials by email Literature Review of Focal Segmental Glomerulosclerosis trials Research Report on Focal Segmental Glomerulosclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
BI 764198, Placebo - Focal Segmental Glomerulosclerosis
Phase 3RecruitingBoehringer Ingelheim2862026-02-162026-10-28

Narrower conditions

Glomerulosclerosis, Focal Segmental (1)

Broader conditions

Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Glomerulonephritis (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Nephritis (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Sponsors

Boehringer Ingelheim (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  China (1)  ·  Croatia (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Finland (1)  ·  France (1)  ·  Georgia (1)  ·  Germany (1)  ·  Greece (1)

NIH funding

2025 (1)